Cidara develops drugs to prevent influenza in individuals at higher risk of complications. Merck has been seeking deals to ...

Major stock indexes finished mixed Friday, with the Dow Jones Industrial Average declining for a second straight session but ...

Share your thoughts and join the conversation in the comments.

Investors should be looking for the S&P 500 to dip below its 50-day moving average to assess if there's more weakness to come ...

The first 10 months of 2025 have been rather quiet when it comes to stock splits, but we're starting to see more activity. In ...

Oil prices moved higher yesterday, settling just shy of 0.5% higher, despite a bearish weekly Energy Information ...

Stocks are trading at some of the highest valuations in history. According to the Buffett Indicator, which compares total U.S ...

Experts recommend six stocks, including ICICI Bank and Bajaj Finserv, poised for potential gains in the next 1-2 weeks, due ...

Nov 14 (Reuters) - Australian shares fell nearly 1.5% on Friday, sinking into a sea of red and hitting their lowest level ...

Sudeep Shah believes the Nifty Pharma index is likely to give the trendline breakout in the next couple of trading sessions.

The mood around BYD in Hong Kong on Monday felt heavy after the company reported that its October vehicle sales fell 12% from ...

IT stocks extended their winning run for 3rd straight session with optimism lifting Nifty IT index to its highest level since mid-September ...